|
Volumn 16 Suppl, Issue , 2009, Pages 2-10
|
Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HUMAN;
MORTALITY;
MYELODYSPLASTIC SYNDROME;
PRACTICE GUIDELINE;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
HUMANS;
MYELODYSPLASTIC SYNDROMES;
PRACTICE GUIDELINES AS TOPIC;
TREATMENT OUTCOME;
|
EID: 77649308061
PISSN: None
EISSN: 15262359
Source Type: Journal
DOI: 10.1177/107327480901604s01 Document Type: Review |
Times cited : (13)
|
References (27)
|